"Anthrax Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent ANTHRAX.
| Descriptor ID |
D022122
|
| MeSH Number(s) |
D20.215.894.135.063
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anthrax Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Anthrax Vaccines".
This graph shows the total number of publications written about "Anthrax Vaccines" by people in this website by year, and whether "Anthrax Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anthrax Vaccines" by people in Profiles.
-
Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model. Infect Immun. 2020 07 21; 88(8).
-
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019. MMWR Recomm Rep. 2019 12 13; 68(4):1-14.
-
Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease. Infect Immun. 2016 Dec; 84(12):3408-3422.
-
Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans. Clin Vaccine Immunol. 2016 Apr; 23(4):326-38.
-
Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults. Vaccine. 2014 Oct 29; 32(47):6284-93.
-
Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. Vaccine. 2014 Jun 12; 32(28):3548-54.
-
Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial. Vaccine. 2014 Feb 12; 32(8):1019-28.
-
Assessing agreement of repeated binary measurements with an application to the CDC's anthrax vaccine clinical trial. Int J Biostat. 2013 Jul 27; 9(1).
-
Identification of novel and cross-species seroreactive proteins from Bacillus anthracis using a ligation-independent cloning-based, SOS-inducible expression system. Microb Pathog. 2012 Nov-Dec; 53(5-6):250-8.
-
Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial. Vaccine. 2012 Aug 31; 30(40):5875-9.